Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2024-03-11

EMA Withdrawn: Pramipexole Accord (pramipexole dihydrochloride monohydrate) — Accord Healthcare S.L.U.

View source ↗

Summary

Withdrawn EMA decision for Pramipexole Accord (pramipexole dihydrochloride monohydrate) by Accord Healthcare S.L.U., affecting Parkinson's disease and Restless …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole Accord (pramipexole dihydrochloride monohydrate)

Snippet

Status: Withdrawn. Therapeutic area: Parkinson Disease;Restless Legs Syndrome. MAH: Accord Healthcare S.L.U.. Decision date: 20/11/2020